Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 2
2004 3
2005 2
2006 1
2007 2
2011 2
2012 4
2013 4
2014 2
2015 4
2016 3
2017 1
2018 3
2019 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

31 results
Results by year
Filters applied: . Clear all
Page 1
A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc) in patients with locally advanced or metastatic cancer.
Greil R, Greil-Ressler S, Weiss L, Schönlieb C, Magnes T, Radl B, Bolger GT, Vcelar B, Sordillo PP. Greil R, et al. Among authors: vcelar b. Cancer Chemother Pharmacol. 2018 Oct;82(4):695-706. doi: 10.1007/s00280-018-3654-0. Epub 2018 Aug 3. Cancer Chemother Pharmacol. 2018. PMID: 30074076 Free PMC article. Clinical Trial.
Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals.
Bolger GT, Licollari A, Tan A, Greil R, Vcelar B, Greil-Ressler S, Weiss L, Schönlieb C, Magnes T, Radl B, Majeed M, Sordillo PP. Bolger GT, et al. Among authors: vcelar b. Cancer Chemother Pharmacol. 2019 Feb;83(2):265-275. doi: 10.1007/s00280-018-3730-5. Epub 2018 Nov 14. Cancer Chemother Pharmacol. 2019. PMID: 30430227
Effect of liposomal curcumin on red blood cells in vitro.
Storka A, Vcelar B, Klickovic U, Gouya G, Weisshaar S, Aschauer S, Helson L, Wolzt M. Storka A, et al. Among authors: vcelar b. Anticancer Res. 2013 Sep;33(9):3629-34. Anticancer Res. 2013. PMID: 24023289
31 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page